Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

Mughal ruler Aurangzeb’s grave in Maharashtra’s Khuldabad has become a target of fringe right-wing groups, who are demanding its demolition. The 17th-century emperor is once again back in the news and ...

Rosie O'Donnell recently relocated to Ireland with her her 12-year-old child, Clay, and with her new home comes a new journey ...

Rosie O'Donnell provides an update on her weight loss journey during a TikTok video posted on Thursday, March 20. The Emmy Award winner shares that she has continued to lose weight since starting ...

Rosie O’Donnell has found her recent weight loss “completely shocking”. The 62-year-old comic and actress, who suffers from ...

Rosie O'Donnell is giving an update on her weight loss journey.

American pharmaceutical company Eli Lilly has launched its drug, Mounjaro, in India. Mounjaro is administered as a ...

Lexaria Bioscience Corp., a global innovator in drug delivery platforms, announces that dosing has begun in its fluorescently tagged DehydraTECH-semaglutide ("FTS") rodent biodistribution study.

US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...